{"id":1629,"date":"2023-05-11T16:54:11","date_gmt":"2023-05-11T16:54:11","guid":{"rendered":"https:\/\/dessevproject.eu\/?p=1629"},"modified":"2023-05-11T16:54:11","modified_gmt":"2023-05-11T16:54:11","slug":"clinical-practice-guidelines-by-the-infectious-diseases-society-of-america-2018-update-on-diagnosis-treatment-chemoprophylaxis-and-institutional-outbreak-management-of-seasonal-influenza","status":"publish","type":"post","link":"https:\/\/dessevproject.eu\/pl\/clinical-practice-guidelines-by-the-infectious-diseases-society-of-america-2018-update-on-diagnosis-treatment-chemoprophylaxis-and-institutional-outbreak-management-of-seasonal-influenza\/","title":{"rendered":"Wytyczne praktyki klinicznej Ameryka\u0144skiego Towarzystwa Chor\u00f3b Zaka\u017anych (Infectious Diseases Society of America) z 2018 r. dotycz\u0105ce diagnostyki, leczenia, chemioprofilaktyki i instytucjonalnego zarz\u0105dzania ogniskami grypy sezonowej"},"content":{"rendered":"<p>Autorzy: Timothy M. Uyeki, Henry H. Bernstein, John S. Bradley, Janet A. Englund, Thomas M. File Jr, Alicia M. Fry, Stefan Gravenstein, Frederick G. Hayden, Scott A. Harper, Jon Mark Hirshon, Michael G. Ison, B. Lynn Johnston, Shandra L. Knight, Allison McGeer, Laura E. Riley, Cameron R. Wolfe, Paul E. Alexander, Andrew T. Pavia<\/p>\n\n\n\n<p>Streszczenie: Niniejszy dokument zawiera nowe informacje dotycz\u0105ce bada\u0144 diagnostycznych, leczenia i chemioprofilaktyki lekami przeciwwirusowymi oraz kwestii zwi\u0105zanych z instytucjonalnym zarz\u0105dzaniem ogniskami grypy sezonowej. Niniejsze wytyczne praktyki klinicznej stanowi\u0105 aktualizacj\u0119 wytycznych opublikowanych przez Infectious Diseases Society of America (IDSA) w 2009 roku, przed pandemi\u0105 grypy H1N1 w 2009 roku.<\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/dessevproject.eu\/wp-content\/uploads\/2023\/05\/78.-Clinical-Practice-Guidelines-by-the-Infectious-Diseases-Society-of-America-2018-Update-on-Diagnosis-Treatment-Chemoprophyl.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Osadzone z 78. Clinical Practice Guidelines by the Infectious Diseases Society of America 2018 Update on Diagnosis, Treatment, Chemoprophyl.\"><\/object><a id=\"wp-block-file--media-229504bd-a055-490e-b644-3e5823a6f833\" href=\"https:\/\/dessevproject.eu\/wp-content\/uploads\/2023\/05\/78.-Clinical-Practice-Guidelines-by-the-Infectious-Diseases-Society-of-America-2018-Update-on-Diagnosis-Treatment-Chemoprophyl.pdf\">78. Clinical Practice Guidelines by the Infectious Diseases Society of America 2018 Update on Diagnosis, Treatment, Chemoprophyl<\/a><\/div>","protected":false},"excerpt":{"rendered":"<p>Niniejszy dokument zawiera nowe informacje dotycz\u0105ce bada\u0144 diagnostycznych, leczenia i chemioprofilaktyki lekami przeciwwirusowymi oraz kwestii zwi\u0105zanych z instytucjonalnym zarz\u0105dzaniem ogniskami grypy sezonowej. Niniejsze wytyczne praktyki klinicznej stanowi\u0105 aktualizacj\u0119 wytycznych opublikowanych przez Infectious Diseases Society of America (IDSA) w 2009 roku, przed pandemi\u0105 grypy H1N1 w 2009 roku. <\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"default","ast-global-header-display":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"categories":[19,15,14],"tags":[],"class_list":["post-1629","post","type-post","status-publish","format-standard","hentry","category-less-important","category-medical","category-repository"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"admin","author_link":"https:\/\/dessevproject.eu\/pl\/author\/admin\/"},"uagb_comment_info":0,"uagb_excerpt":"This document addresses new information regarding diagnostic testing, treatment and chemoprophylaxis with antiviral medications, and issues related to institutional outbreak management for seasonal influenza. These clinical practice guidelines are an update of the guidelines published by the Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza pandemic.","_links":{"self":[{"href":"https:\/\/dessevproject.eu\/pl\/wp-json\/wp\/v2\/posts\/1629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dessevproject.eu\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dessevproject.eu\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dessevproject.eu\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dessevproject.eu\/pl\/wp-json\/wp\/v2\/comments?post=1629"}],"version-history":[{"count":1,"href":"https:\/\/dessevproject.eu\/pl\/wp-json\/wp\/v2\/posts\/1629\/revisions"}],"predecessor-version":[{"id":1630,"href":"https:\/\/dessevproject.eu\/pl\/wp-json\/wp\/v2\/posts\/1629\/revisions\/1630"}],"wp:attachment":[{"href":"https:\/\/dessevproject.eu\/pl\/wp-json\/wp\/v2\/media?parent=1629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dessevproject.eu\/pl\/wp-json\/wp\/v2\/categories?post=1629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dessevproject.eu\/pl\/wp-json\/wp\/v2\/tags?post=1629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}